Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Identification of novel PPARgamma target genes by integrated analysis of ChIP-on-chip and microarray expression data during adipocyte differentiation.

Nakachi Y, Yagi K, Nikaido I, Bono H, Tonouchi M, Schönbach C, Okazaki Y.

Biochem Biophys Res Commun. 2008 Jul 25;372(2):362-6. doi: 10.1016/j.bbrc.2008.05.037. Epub 2008 May 19.

PMID:
18489901
2.
3.

Bixin regulates mRNA expression involved in adipogenesis and enhances insulin sensitivity in 3T3-L1 adipocytes through PPARgamma activation.

Takahashi N, Goto T, Taimatsu A, Egawa K, Katoh S, Kusudo T, Sakamoto T, Ohyane C, Lee JY, Kim YI, Uemura T, Hirai S, Kawada T.

Biochem Biophys Res Commun. 2009 Dec 25;390(4):1372-6. doi: 10.1016/j.bbrc.2009.10.162. Epub 2009 Nov 3.

PMID:
19891958
4.

Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis.

Nielsen R, Pedersen TA, Hagenbeek D, Moulos P, Siersbaek R, Megens E, Denissov S, Børgesen M, Francoijs KJ, Mandrup S, Stunnenberg HG.

Genes Dev. 2008 Nov 1;22(21):2953-67. doi: 10.1101/gad.501108.

5.

Identification of novel PPARgamma target genes in primary human adipocytes.

Perera RJ, Marcusson EG, Koo S, Kang X, Kim Y, White N, Dean NM.

Gene. 2006 Mar 15;369:90-9. Epub 2005 Dec 27.

PMID:
16380219
6.

Human adipocyte fatty acid-binding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor gamma ligands.

Rival Y, Stennevin A, Puech L, Rouquette A, Cathala C, Lestienne F, Dupont-Passelaigue E, Patoiseau JF, Wurch T, Junquéro D.

J Pharmacol Exp Ther. 2004 Nov;311(2):467-75. Epub 2004 Jul 23.

7.

Transcriptional activation of Cidec by PPARgamma2 in adipocyte.

Kim YJ, Cho SY, Yun CH, Moon YS, Lee TR, Kim SH.

Biochem Biophys Res Commun. 2008 Dec 5;377(1):297-302. doi: 10.1016/j.bbrc.2008.09.129. Epub 2008 Oct 7.

PMID:
18845124
8.

Augmentation of PPARgamma-TAZ interaction contributes to the anti-adipogenic activity of KR62980.

Jung H, Lee MS, Jang EJ, Ahn JH, Kang NS, Yoo SE, Bae MA, Hong JH, Hwang ES.

Biochem Pharmacol. 2009 Nov 15;78(10):1323-9. doi: 10.1016/j.bcp.2009.07.001. Epub 2009 Jul 8.

PMID:
19591806
9.

Identification of promethin and PGLP as two novel up-regulated genes in PPARgamma1-induced adipogenic mouse liver.

Yu S, Viswakarma N, Batra SK, Sambasiva Rao M, Reddy JK.

Biochimie. 2004 Nov;86(11):743-61.

PMID:
15589683
10.

Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.

Choi SS, Cha BY, Lee YS, Yonezawa T, Teruya T, Nagai K, Woo JT.

Life Sci. 2009 Jun 19;84(25-26):908-14. doi: 10.1016/j.lfs.2009.04.001. Epub 2009 Apr 17.

PMID:
19376135
11.

De-novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis.

Hamza MS, Pott S, Vega VB, Thomsen JS, Kandhadayar GS, Ng PW, Chiu KP, Pettersson S, Wei CL, Ruan Y, Liu ET.

PLoS One. 2009;4(3):e4907. doi: 10.1371/journal.pone.0004907. Epub 2009 Mar 20.

12.

Very long-chain-fatty acids enhance adipogenesis through coregulation of Elovl3 and PPARγ in 3T3-L1 cells.

Kobayashi T, Fujimori K.

Am J Physiol Endocrinol Metab. 2012 Jun 15;302(12):E1461-71. doi: 10.1152/ajpendo.00623.2011. Epub 2012 Mar 20.

13.

Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation.

Hu Y, Davies GE.

Phytomedicine. 2009 Sep;16(9):864-73. doi: 10.1016/j.phymed.2009.03.002. Epub 2009 Apr 28.

PMID:
19403287
14.

miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression.

Kim SY, Kim AY, Lee HW, Son YH, Lee GY, Lee JW, Lee YS, Kim JB.

Biochem Biophys Res Commun. 2010 Feb 12;392(3):323-8. doi: 10.1016/j.bbrc.2010.01.012. Epub 2010 Jan 7.

PMID:
20060380
15.

The G0/G1 switch gene 2 is a novel PPAR target gene.

Zandbergen F, Mandard S, Escher P, Tan NS, Patsouris D, Jatkoe T, Rojas-Caro S, Madore S, Wahli W, Tafuri S, Müller M, Kersten S.

Biochem J. 2005 Dec 1;392(Pt 2):313-24.

16.

Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5B-PPARgamma pathway.

Kawai M, Namba N, Mushiake S, Etani Y, Nishimura R, Makishima M, Ozono K.

J Mol Endocrinol. 2007 Feb;38(1-2):19-34.

PMID:
17242167
17.

Identification of a novel prostaglandin reductase reveals the involvement of prostaglandin E2 catabolism in regulation of peroxisome proliferator-activated receptor gamma activation.

Chou WL, Chuang LM, Chou CC, Wang AH, Lawson JA, FitzGerald GA, Chang ZF.

J Biol Chem. 2007 Jun 22;282(25):18162-72. Epub 2007 Apr 21.

18.

Sargaquinoic acid and sargahydroquinoic acid from Sargassum yezoense stimulate adipocyte differentiation through PPARalpha/gamma activation in 3T3-L1 cells.

Kim SN, Choi HY, Lee W, Park GM, Shin WS, Kim YK.

FEBS Lett. 2008 Oct 15;582(23-24):3465-72. doi: 10.1016/j.febslet.2008.09.011. Epub 2008 Sep 17.

19.

Gene expression analysis suggests that EBF-1 and PPARgamma2 induce adipogenesis of NIH-3T3 cells with similar efficiency and kinetics.

Akerblad P, Månsson R, Lagergren A, Westerlund S, Basta B, Lind U, Thelin A, Gisler R, Liberg D, Nelander S, Bamberg K, Sigvardsson M.

Physiol Genomics. 2005 Oct 17;23(2):206-16. Epub 2005 Aug 16.

20.

Citrate carrier promoter is target of peroxisome proliferator-activated receptor alpha and gamma in hepatocytes and adipocytes.

Damiano F, Gnoni GV, Siculella L.

Int J Biochem Cell Biol. 2012 Apr;44(4):659-68. doi: 10.1016/j.biocel.2012.01.003. Epub 2012 Jan 10.

PMID:
22249025

Supplemental Content

Support Center